Crossmark

High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease

Crossref DOI link: https://doi.org/10.1038/s41531-022-00278-y

Published Online: 2022-02-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Antoniou, Nasia http://orcid.org/0000-0002-3520-3663
Prodromidou, Kanella

Kouroupi, Georgia

Boumpoureka, Ioanna

Samiotaki, Martina

Panayotou, George

Xilouri, Maria http://orcid.org/0000-0001-7038-0780
Kloukina, Ismini

Stefanis, Leonidas http://orcid.org/0000-0003-3569-8990
Grailhe, Regis

Taoufik, Era

Matsas, Rebecca http://orcid.org/0000-0002-4027-348X
License Information

Text and Data Mining valid from 2022-02-11

Version of Record valid from 2022-02-11
More Information

Article History

Received: 8 April 2021

Accepted: 12 January 2022

First Online: 11 February 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below